Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
72 participants
OBSERVATIONAL
2024-10-23
2025-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Point-spectroscopy Trial
NCT05183698
Evaluation of MolecuLight i:X as an Adjunctive Fluorescence Imaging Tool to Clinical Signs and Symptoms for the Identification of Bacteria-containing Wounds
NCT03540004
A Prospective, Pilot Evaluation of Device Equivalence
NCT03754426
A Prospective Evaluation of Clinical Equivalence Between iX and PID
NCT03967405
Presence of Fluorescence Signature to Predict Graft Failure Using MolecuLight i:X
NCT04185636
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MolecuLight DX Imaging Device
The MolecuLight DX Imaging Device is a fluorescence imaging device intended to acquire images from wounds. This will not alter the participant's standard of care treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing to comply with all study procedures and availability for the duration of the study
* Male or female, aged over 22 years old
* Presented with diabetic foot ulcers, venous, arterial and pressure ulcers
* Wound size is greater than 0.5 cm2
* The wound has well-defined wound borders
Exclusion Criteria
* Wound without clearly defined wound borders
* Wound located in a difficult to reach/measure location
* Any contra-indication to routine wound care and/or monitoring
* Wounds with a length greater than 18.5cm or a width greater than 13.5cm.
* Tunneled or undermined wounds
22 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MolecuLight Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Mayer Institute
Hamilton, Ontario, Canada
SHN Research Institute
Scarborough Village, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.